FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1345281000168106: ascorbic acid 50 mg + colloidal anhydrous silica 53.53 mg + Vaccinium macrocarpon extract 250 mg capsule (medicinal product unit of use)


Status: current, Defined. Date: 31-Jul 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3422041000168116 ascorbic acid 50 mg + colloidal anhydrous silica 53.53 mg + Vaccinium macrocarpon extract 250 mg capsule (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3422051000168119 cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule en Synonym Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule Is a cranberry extract + colloidal anhydrous silica + ascorbic acid true Inferred relationship Some
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule Is a medicinal product unit of use true Inferred relationship Some
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has manufactured dose form capsule true Inferred relationship Some
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has unit of use capsule true Inferred relationship Some 1761794805
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has Australian BoSS cranberry extract true Inferred relationship Some 768950236
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has intended active ingredient cranberry extract true Inferred relationship Some 768950236
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has intended active ingredient colloidal anhydrous silica true Inferred relationship Some 1761794804
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has Australian BoSS colloidal anhydrous silica true Inferred relationship Some 1761794804
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has Australian BoSS ascorbic acid true Inferred relationship Some 1211180604
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule has intended active ingredient ascorbic acid true Inferred relationship Some 1211180604

Inbound Relationships Type Active Source Characteristic Refinability Group
cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule, 30 has MPUU True cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule Inferred relationship Some 1
Cranberry 35 000 mg Plus (Blooms) capsule Is a True cranberry extract 250 mg + colloidal anhydrous silica 53.53 mg + ascorbic acid 50 mg capsule Inferred relationship Some

Reference Sets

Medicinal product unit of use reference set

Back to Start